Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Haller

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Current Diabetes Reports|September 16, 2015
Can we prevent type 1 diabetes?Giovanna Beauchamp, Michael J Haller
European Endocrinology|April 11, 2018
Updates on Immune Therapies in Type 1 DiabetesBimota Nambam, Michael J Haller
Pediatric Diabetes|January 24, 2008
Cytokines and type 1 diabetes complications: casual or causal association?Michael J Haller, Desmond A Schatz
The Journal of Pediatrics|July 22, 2009
In pursuit of lower A1cMichael J Haller, Janet H Silverstein
Pediatric Diabetes|September 5, 2008
What's in a name? Thyroid autoimmunity in obese patients with T1DMichael J Haller, Desmond A Schatz
Pediatric Endocrinology Reviews : PER|June 7, 2007
Endocrine complications of childhood cancer therapy: evaluation and managementMichael J Haller, Desmond A Schatz
Pediatric Diabetes|July 15, 2016
The DIPP project: 20 years of discovery in type 1 diabetesMichael J Haller, Desmond A Schatz
The New England Journal of Medicine|November 12, 2005
CD3-antibody therapy in new-onset type 1 diabetes mellitusMichael J Haller, Desmond A Schatz
Pediatric Diabetes|January 26, 2018
Presymptomatic screening for autoimmune β-cell disorder: Baby steps toward prevention?Laura M Jacobsen, Henry Anhalt, Michael J Haller
Diabetes Care|March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Michael J Haller
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Current Diabetes Reports|September 16, 2015
Can we prevent type 1 diabetes?Giovanna Beauchamp, Michael J Haller
European Endocrinology|April 11, 2018
Updates on Immune Therapies in Type 1 DiabetesBimota Nambam, Michael J Haller
Pediatric Diabetes|January 24, 2008
Cytokines and type 1 diabetes complications: casual or causal association?Michael J Haller, Desmond A Schatz
The Journal of Pediatrics|July 22, 2009
In pursuit of lower A1cMichael J Haller, Janet H Silverstein
Pediatric Diabetes|September 5, 2008
What's in a name? Thyroid autoimmunity in obese patients with T1DMichael J Haller, Desmond A Schatz
Pediatric Endocrinology Reviews : PER|June 7, 2007
Endocrine complications of childhood cancer therapy: evaluation and managementMichael J Haller, Desmond A Schatz
Pediatric Diabetes|July 15, 2016
The DIPP project: 20 years of discovery in type 1 diabetesMichael J Haller, Desmond A Schatz
The New England Journal of Medicine|November 12, 2005
CD3-antibody therapy in new-onset type 1 diabetes mellitusMichael J Haller, Desmond A Schatz
Pediatric Diabetes|January 26, 2018
Presymptomatic screening for autoimmune β-cell disorder: Baby steps toward prevention?Laura M Jacobsen, Henry Anhalt, Michael J Haller
Diabetes Care|March 1, 2007
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Michael J Haller
Pageof 21